Nasdaq Dare News Today

HC Wainwright reiterated their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report published on Wednesday morning, Benzinga reports. They currently have a $6.00 price objective on the biotechnology company’s stock. A number of other research analysts also recently issued reports on the stock. Dawson James downgraded shares of Daré […]

Daré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at HC Wainwright in a report released on Wednesday, Benzinga reports. They currently have a $6.00 price target on the biotechnology company’s stock. Several other research analysts have also weighed in on the stock. Dawson James lowered shares of […]

Daré Bioscience (NASDAQ:DARE – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at HC Wainwright in a research report issued on Monday, Benzinga reports. They presently have a $6.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s FY2025 earnings at $0.10 EPS, FY2026 earnings […]

SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced changes in...

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 979,200 shares, an increase of 76.8% from the November 30th total of 553,900 shares. Based on an average daily volume of 494,500 shares, the days-to-cover ratio […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.42 and traded as low as $0.33. Daré Bioscience shares last traded at $0.34, with a volume of 233,070 shares changing hands. Analysts Set New Price […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report) was the recipient of a significant growth in short interest in the month of August. As of August 31st, there was short interest totalling 836,800 shares, a growth of 19.4% from the August 15th total of 700,900 shares. Based on an average daily volume of 307,200 shares, […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Free Report)’s stock price passed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.92 and traded as low as $0.62. Daré Bioscience shares last traded at $0.63, with a volume of 280,238 shares trading hands. […]

HC Wainwright reissued their buy rating on shares of Daré Bioscience (NASDAQ:DARE – Free Report) in a report issued on Friday, Benzinga reports. They currently have a $7.00 price objective on the biotechnology company’s stock. HC Wainwright also issued estimates for Daré Bioscience’s Q1 2024 earnings at ($0.07) EPS, Q2 2024 earnings at $0.00 EPS, […]

Daré Bioscience, Inc. (NASDAQ:DARE – Get Rating) – Brookline Capital Management issued their Q3 2023 earnings estimates for Daré Bioscience in a report released on Monday, June 5th. Brookline Capital Management analyst K. Dolliver expects that the biotechnology company will earn ($0.07) per share for the quarter. Brookline Capital Management currently has a “Buy” rating […]